Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2)

Clinical trial NCT03941132 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03941132
Sponsor: University of British Columbia
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2021-01-04
Primary completion: 2026-02-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.